Third, we test genetic moderation for all three modifiable risk scores with APOE risk stratification followed by a previously published AD-GRS (Sapkota and Dixon, 2018) to predict EF trajectories in non-demented older adults. The gene discussed is APOE; the disease is Alzheimer disease.